TickerFacts.

Cresco Labs Inc. (CRLBF): Revenue

Annual figures by period end, from SEC filings.

$655.85M
Year ended 2025-12-31
$770.88M2023-12-31: $770.88M2024-12-31: $724.34M2025-12-31: $655.85M$655.85M
2023-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$655.85M-9.5%2026-03-06, From 2025-01-01
2024-12-31$724.34M-6.0%2026-03-06, From 2024-01-01
2023-12-31$770.88Mn/a2025-03-14, From 2023-01-01

Revenue at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Cresco Labs Inc. (CRLBF)2025-12-31$655.85M-9.5%
Ascend Wellness Holdings, Inc. (AAWH)2025-12-31$500.58M-10.9%
Tilray Brands, Inc. (TLRY)2026-05-31$915.45M+11.5%
USANA Health Sciences Inc (USNA)2026-01-03$925.26M+8.3%
Trulieve Cannabis Corp. (TRLV)2025-12-31$1.18B-0.4%
Curaleaf Holdings, Inc. (CURLF)2025-12-31$1.27B-5.0%
Jushi Holdings Inc. (JUSH)2025-12-31$262.91M+2.1%
biote Corp. (BTMD)2025-12-31$192.22M-2.5%
Glass House Brands Inc. (GLAS)2025-12-31$181.98M-9.4%

Compare CRLBF, AAWH, TLRY, USNA side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗